Author: Phil Prime

We catch up with Dr Alexis Webb and find out about the upcoming Early Detection of Cancer Conference, the importance of collaboration and why these are exciting times for the field…

CRISPR-Cas9 is a world-renowned genome editing tool, but much of the hype has been focused on direct clinical applications. However, there is clear potential for utilising the system in functional genomic screens to develop new cancer medicines…

Our policy department give us an update on the current state of play on post-Brexit science funding, what you can do to help and what we know about the Government’s ‘Plan B’…

Cancer Research UK is proud to launch the Black Leaders in Cancer PhD Scholarship Programme- helping develop the next generation of Black leaders in cancer research

Cancer Research Matters provokes conversation around cancer science, how it shapes our understanding of the disease and the challenges we…

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach – here’s how our new strategy will help

We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on?

We know that cancer research saves and improves lives. What is less well known is the role of cancer research…

Is the Government’s implementation plan for its 10-year clinical research vision any more than just rhetoric? Our policy team give us the low-down…

Cachexia, sometimes described as a metabolic mutiny, is a condition where lean muscle wastes away, leading to extreme weight loss…